A patient with stage IV type 4 advanced gastric cancer who had a complete pathological response to short-term treatment with S-1 alone

被引:2
|
作者
Ishido, Kenji [1 ]
Koizumi, Wasaburo [1 ]
Tanabe, Satoshi [1 ]
Higuchi, Katsuhiko [1 ]
Sasaki, Tohru [1 ]
Katada, Chikatoshi [1 ]
Azuma, Mizutomo [1 ]
Salgenji, Katsunori [1 ]
Futawatari, Nobue [2 ]
Saegusa, Makoto [3 ]
机构
[1] Kitasato Univ, E Hosp, Dept Gastroenterol, Kanagawa 2288520, Japan
[2] Kitasato Univ, E Hosp, Dept Surg, Kanagawa 2288520, Japan
[3] Kitasato Univ, E Hosp, Dept Pathol, Kanagawa 2288520, Japan
关键词
chemotherapy; gastric cancer; S-1;
D O I
10.1097/CAD.0b013e32830d58a6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
An 81-year-old woman presented with dysphagia. Stage IV (cT3, cN3, cH0, cM1) type 4 advanced gastric cancer was diagnosed. The left adrenal gland and the paragastric, mediastinal, and abdominal para-aortic lymph nodes were enlarged. Ascites was present The patient started to receive S-1 (100 mg/day), given orally for 4 weeks followed by 2 weeks of rest. During the first course of treatment, grade 2 anorexia, grade 2 vomiting, and grade 2 diarrhea developed. Treatment with S-1 was therefore discontinued on day 27 The tumor had shrunk and was severely deformed. There was marked narrowing of the pyloric antrum. Abdominal computed tomography revealed that ascites and enlargement of the left adrenal gland and paragastric lymph nodes had resolved. To ensure adequate oral intake and improve the patient's quality of life, a total gastrectomy with a limited (D1) lymph node dissection was performed. The primary gastric tumor, resected lymph nodes, and a peritoneal-lavage specimen were all negative for tumor. Histologically, the tumor had a complete pathological response to S-1. Two years after surgery, the patient is alive, with no evidence of metastasis or recurrence.
引用
收藏
页码:921 / 925
页数:5
相关论文
共 50 条
  • [41] Randomized phase III study of S-1 alone versus S-1 plus docetaxel (DOC) in the treatment for advanced gastric cancer (AGC): The START trial update.
    Fujii, M.
    Kim, Y. H.
    Satoh, T.
    Hosaka, H.
    Kim, T.
    Tsuji, A.
    Inokuchi, M.
    Takagane, A.
    Oh, S. C.
    Tanabe, K.
    Okuno, T.
    Chin, K.
    Ura, T.
    Lee, J. I.
    Kakudo, Y.
    Yamaguchi, K.
    Iijima, S.
    Takeuchi, M.
    Kim, H.
    Nakajima, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [42] Impacts of fluorouracil-metabolizing enzymes on the outcomes of patients treated with S-1 alone or S-1 plus cisplatin for first-line treatment of advanced gastric cancer
    Koizumi, Wasaburo
    Tanabe, Satoshi
    Azuma, Mizutomo
    Ishido, Kenji
    Nishimura, Ken
    Sasaki, Tohru
    Nakatani, Kento
    Higuchi, Katsuhiko
    Nakayama, Norisuke
    Katada, Chikatoshi
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (01) : 162 - 170
  • [43] Clinical and pathological disappearance of peritoneal dissemination in a patient with advanced gastric cancer receiving chemotherapy with S-1 and low-dose cisplatin
    Akatsu Y.
    Saikawa Y.
    Kubota T.
    Yoshida M.
    Furukawa T.
    Otani Y.
    Kumai K.
    Kitajima M.
    Gastric Cancer, 2004, 7 (2) : 128 - 133
  • [44] Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients
    Masaaki Saito
    Hirokazu Kiyozaki
    Osamu Takata
    Koichi Suzuki
    Toshiki Rikiyama
    World Journal of Surgical Oncology, 12
  • [45] Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients
    Saito, Masaaki
    Kiyozaki, Hirokazu
    Takata, Osamu
    Suzuki, Koichi
    Rikiyama, Toshiki
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
  • [46] Meta-Enrichment Analyses to Identify Advanced Gastric Cancer Patients Who Achieve a Higher Response to S-1/Cisplatin
    Takeuchi, Madoka
    Ajani, Jaffer A.
    Fang, Xuemin
    Pfeiffer, Per
    Takeuchi, Masahiro
    van Laarhoven, Hanneke W. M.
    CANCERS, 2019, 11 (06)
  • [47] Pathological Complete Response and Long-Term Survival in a Very Elderly Patient after Neoadjuvant Chemotherapy for Locally Advanced, Unresectable Gastric Cancer
    Izuishi, Kunihiko
    Kobayashi, Mitsuyoshi
    Sano, Takanori
    Mori, Hirohito
    Ebara, Kazuo
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2014, 2014
  • [48] Long-term Survival Outcomes of Advanced Gastric Cancer Patients Who Achieved a Pathological Complete Response with Neoadjuvant Chemotherapy: A Systematic Review of the Literature
    Cho, Haruhiko
    Nakamura, Junichi
    Asaumi, Yoshihide
    Yabusaki, Hiroshi
    Sakon, Masahiro
    Takasu, Naoki
    Kobayashi, Tatsunori
    Aoki, Taro
    Shiraishi, Osamu
    Kishimoto, Hirofumi
    Nunobe, Souya
    Yanagisawa, Shinji
    Suda, Takeshi
    Ueshima, Shigeyuki
    Matono, Satoru
    Maruyama, Hiroshi
    Tatsumi, Mitsutoshi
    Seya, Tomoko
    Tanizawa, Yutaka
    Yoshikawa, Takaki
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (03) : 787 - 792
  • [49] Long-term Survival Outcomes of Advanced Gastric Cancer Patients Who Achieved a Pathological Complete Response with Neoadjuvant Chemotherapy: A Systematic Review of the Literature
    Haruhiko Cho
    Junichi Nakamura
    Yoshihide Asaumi
    Hiroshi Yabusaki
    Masahiro Sakon
    Naoki Takasu
    Tatsunori Kobayashi
    Taro Aoki
    Osamu Shiraishi
    Hirofumi Kishimoto
    Souya Nunobe
    Shinji Yanagisawa
    Takeshi Suda
    Shigeyuki Ueshima
    Satoru Matono
    Hiroshi Maruyama
    Mitsutoshi Tatsumi
    Tomoko Seya
    Yutaka Tanizawa
    Takaki Yoshikawa
    Annals of Surgical Oncology, 2015, 22 : 787 - 792
  • [50] Chemotherapy using S-1 plus low dose CDDP after noncurative surgery for stage III and IV advanced gastric cancer.
    Takahashi, N
    Nimura, H
    Mitsumori, N
    Aiba, K
    Yanaga, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 371S - 371S